Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.01 USD | 0.00% | +0.18% | +2.51% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 214 |
Enterprise Value (EV) 1 | 213.4 |
P/E ratio | 34 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | - |
EV / FCF | -1,429,157 x |
FCF Yield | -0% |
Price to Book | -44.1 x |
Nbr of stocks (in thousands) | 19,929 |
Reference price 2 | 10.74 |
Announcement Date | 3/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | - | - |
EBIT | - | - | -1.023 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -0.005059 | -0.0719 | 6.073 |
Net income 1 | -0.005059 | -0.0719 | 6.073 |
Net margin | - | - | - |
EPS | - | -0.0173 | 0.3159 |
Free Cash Flow | - | - | -149.3 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 3/17/22 | 4/17/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 0.01 | 0.23 | - |
Net Cash position 1 | - | - | 0.67 |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | - | -149 |
ROE (net income / shareholders' equity) | - | 252% | -248% |
ROA (Net income/ Total Assets) | - | - | -0.82% |
Assets 1 | - | - | -737.3 |
Book Value Per Share 2 | -0 | -0.0100 | -0.2400 |
Cash Flow per Share | - | 0 | 0.0300 |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 3/17/22 | 4/17/23 | 3/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.51% | 141M | |
+111.60% | 7.06B | |
+2.48% | 986M | |
+98.02% | 883M | |
+14.88% | 759M | |
+2.11% | 666M | |
+2.33% | 615M | |
-.--% | 600M | |
+8.61% | 528M | |
-.--% | 500M |
- Stock Market
- Equities
- ISRL Stock
- Financials Israel Acquisitions Corp